Viloxazine Plus Caffeine Increases Insomnia Likelihood in Adults With ADHD
Using viloxazine extended-release (ER) capsules with caffeine among adults significantly increases the likelihood of insomnia, but may not increase the likelihood of experiencing other caffeine-related adverse events (AEs), according to study results presented at Psych Congress 2022, held from September 17 to 20, 2022, in New Orleans, Louisiana.
Other Articles in this Edition
Preparing Students With ADHD for College
Acetaminophen use during pregnancy can impact kids’ behavior, researchers warn
Study shows birth weight could help identify children at higher risk of psychological issues
Black Girls with ADHD Often Remain Undiagnosed—Here’s How to Spot the Signs
New Study to Understand the Relationship Between ADHD and Suicide Risk
4 Ways Teens Hurt Their Mental Health (Without Even Knowing It)
Viloxazine Plus Caffeine Increases Insomnia Likelihood in Adults With ADHD
How Women Can Manage ADHD When Anxiety Is Skyrocketing At Work